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ABSTRACT
The 2019 novel coronavirus which causes severe acute 
respiratory syndrome (SARS) known as SARS- CoV-2 still 
remains as a global pandemic since its discovery and 
continues to spread across the world, given how highly 
contagious the virus is. We reviewed various articles that 
explore eye involvement in COVID-19 and other human 
coronaviruses, its human manifestations in comparison 
to animal studies and potential mechanism of viral entry 
into the eye surface. Evidence of animal studies depicted 
various complications of coronaviruses infection into 
the eyes, in both anterior and posterior segments of 
the eye. Conjunctival inflammation remains uncommon 
in association with COVID-19, with other ophthalmic 
findings. The risk of transmission via the ocular surface 
remains likely low, though it is inarguably present based 
on preliminary finding of viral load in ocular samples and 
expression of ACE2 on the ocular surface. Testing the tears 
sample for diagnosing SARS- CoV-2 was unreliable due to 
limitations of the testing kits and conflicting evidence of 
the viral titre in the ocular samples. Further larger, more 
precise and specific studies are required to allow us to 
better understand the pattern of virulence underlying 
the associations of SARS- CoV-2 in the eye despite its 
rare occurrence. This review article aims to enhance 
better awareness among clinicians regarding ocular 
manifestations associated with COVID-19 and necessary 
precautions should be implemented to minimise the risk of 
person- to- person especially in the nosocomial setting.
INTRODUCTION
When the novel coronavirus (CoV) which 
causes severe acute respiratory syndrome 
(SARS), namely SARS- CoV-2 or infamously 
known as COVID-19 was first recognised and 
reported since December 2019 in Wuhan, 
China, many of us understood that it is 
another type of severe airway disease. As time 
progresses, unfortunately COVID-19 had 
evolved into a global pandemic affecting 
the health of millions of people across the 
globe with increasing mortality as well. 
The virus has been associated with stroke, 
cardiovascular pathologies, neurological 
manifestations, dermatological signs as well 
as ocular pathologies. This review article 
aims to look into the ocular manifestations 
that have been reported to be associated with 
COVID-19 particularly, to enhance awareness 
among our colleagues of such ocular associa-
tions which can be an early sign of COVID-19 
manifestation.
Human coronaviruses: history
The earliest discovery of human coronavirus 
(HCoV) was reported in 1965 in patients with 
a common cold which was named as B814.1 
Although most coronaviruses infections 
in human are associated with mild clinical 
symptoms, the notably pathogenic strains are 
SARS- CoV, Middle East respiratory syndrome 
Coronavirus (MERS- CoV) and the new 
SARS- CoV-2.2
The novel betacoronavirus, SARS- CoV was 
responsible for the first pandemic of the 
21st century between November 2002 and 
August 2003 that resulted in 8098 cases with 
fatality rate of 9.6% to 11% according to 
WHO.3 4 Two human CoVs were identified 
before SARS- CoV, HCoV- 229E and HCoV- 
OC43.5 6 Following the SARS outbreak, two 
more strains of human coronaviruses were 
found, HCoV- NL63 and HCoV- HKU1.7 8 In 
2012, MERS- CoV was first detected from a 
man who died from severe pneumonia and 
secondary renal failure in Saudi Arabia. The 
virus is responsible for the ongoing epidemic 
of respiratory disease in Middle East Region 
and the deadly outbreak in South Korea.9–11
On 7th January 2020, WHO announced 
the new betacoronavirus following the 
mysterious clusters of infectious respiratory 
disease in Wuhan, China.12 Although the 
virus was named SARS- CoV-2, it was not the 
descendent from SARS- CoV.13 Full genome 
sequencing of SARS- CoV-2 from five patients 
at an early stage of the pandemic had shown 
79.6% similarity to SARS- CoV and 50% to 
MERS- CoV.14 Furthermore, SARS- CoV-2 
shares 96.2% of nucleotide identity with the 
closest bat coronavirus, which confirmed its 
zoonotic origin.15 As of 15th October 2020, 
there have been around 37.1 million cases 
of SARS- CoV-2 globally with a mortality rate 
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